RomSi: Mobile Health Intervention to Enhance Suicide Prevention by Reducing Stigma and Increasing Literacy
NCT ID: NCT06759129
Last Updated: 2025-01-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
214 participants
INTERVENTIONAL
2025-03-31
2025-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
"Youth Aware of Mental Health" in Galicia
NCT06251037
Short Message System (SMS) for Caregivers of Suicidal Patients to Prevent Recidivism of Suicide Attempts
NCT03069560
Prevention of Suicidal Behaviour With Telemedicine Techniques
NCT03043040
Suicide in Urban Natives: Detection and Networks to Combat Events
NCT03136094
Qualitative Assessment of the Brief Contact Intervention "Stay in Contact" in Suicide Prevention
NCT03325478
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Public stigma includes negative beliefs, such as perceiving individuals with suicidal thoughts as "weak" or "selfish." This stigma can be internalized by those experiencing suicidal ideation or behaviour, negatively affecting their self-esteem and increasing their distress and isolation due to fear of rejection. Furthermore, family members and friends who have lost a loved one to suicide also face stigma, complicating their grieving process and increasing their risk of depression.
This context highlights the need for effective interventions to reduce stigma, encourage help-seeking, and provide support for both at-risk individuals and their loved ones.
The goal of this study is to develop and validate a mobile application called RomSi ("Rompiendo el silencio" in Spanish; Breaking the Silence), designed to improve knowledge about suicide, reduce associated stigma, and promote help-seeking behaviours. The app incorporates four intervention approaches that have proven effective in other mental health stigma reduction programs:
1. Psychoeducation,
2. Interpersonal contact,
3. Cognitive flexibility, and
4. Values-based work.
Additionally, the app will leverage innovative tools like Ecological Momentary Assessment (EMA) to collect real-time data and personalize the intervention to each participant's needs. Gamification elements will also be used to enhance motivation and engagement throughout the intervention.
To evaluate the effectiveness of RomSi, a randomized controlled trial (RCT) with a crossover design will be conducted. Participants will be randomly assigned to one of two groups:
* iApp: Immediate use of the app.
* dApp: Delayed use (waitlist control).
The randomization process will use a computer-generated sequence, concealed from researchers until group assignment, and stratified based on stigma levels toward suicide.
Evaluations will occur at five key time points:
* T0 (pre-intervention): Initial questionnaires.
* T1 (post-intervention): After app completion (iApp) or after 14 days of waiting (dApp).
* T2: Follow-up 14 days after T1.
* T3: Follow-up 1 month.
* T4: Follow-up 3 months.
The iApp group will begin using the app immediately after T0 and will have 14 days to complete it, though they may proceed at their own pace. The dApp group will act as a waitlist control, starting the app after completing T1 and following the same evaluation schedule.
During the intervention, EMA will be used to measure stigma levels daily, while suicidal ideation and help-seeking behaviors will be assessed at T0, at 7 days, and at the end of the intervention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Immediate-use
Participants will use the mobile application starting immediately after the baseline assessment (T0) for approximately 14 days or until they complete the app.
Immediate-use of a mobile health application until completion
Participants will use the RomSi app for approximately 14 days, completing all scheduled activities. Throughout the intervention, they will respond to ecological momentary assessments (EMA) designed to evaluate stigma, help-seeking intentions, and suicidal ideation.
The activities within the app will include interactive games aimed at fostering empathy and emotional understanding. Participants will also have continuous access to specialized help contacts to ensure their well-being during the study.
The protocol involves two groups that will receive tailored information based on their specific needs:
1. Individuals with low suicidal ideation and/or self-stigma, who will engage in activities focused on reducing personal stigma.
2. Individuals experiencing suicide bereavement, who will receive support tailored to address their loss and foster resilience.
A follow-up will be carried out one month and three months after the end of the intervention.
Delayed use
Participants will start using the application 14 days after the baseline assessment (T0) and immediately after the T1 assessment.
Delayed use of a mobile health application until completion
Participants assigned to the dApp group (delayed use) will not have access to the RomSi app during the first two weeks of the study. During this period, they will complete ecological momentary assessments (EMA) to evaluate stigma, help-seeking intentions, and suicidal ideation, without engaging in the intervention activities associated with the app.
After completing this initial control phase, participants in the dAPP group will begin using the RomSi app, following the same protocol as the iAPP group. This includes interactive activities, such as games designed to foster empathy and understanding, along with continuous access to specialized help contacts.
This crossover design allows for the immediate effects of the intervention to be compared between groups, while also evaluating changes in pre- and post-intervention measures across both conditions.
A follow-up will be carried out one month and three months after the end of the intervention.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Immediate-use of a mobile health application until completion
Participants will use the RomSi app for approximately 14 days, completing all scheduled activities. Throughout the intervention, they will respond to ecological momentary assessments (EMA) designed to evaluate stigma, help-seeking intentions, and suicidal ideation.
The activities within the app will include interactive games aimed at fostering empathy and emotional understanding. Participants will also have continuous access to specialized help contacts to ensure their well-being during the study.
The protocol involves two groups that will receive tailored information based on their specific needs:
1. Individuals with low suicidal ideation and/or self-stigma, who will engage in activities focused on reducing personal stigma.
2. Individuals experiencing suicide bereavement, who will receive support tailored to address their loss and foster resilience.
A follow-up will be carried out one month and three months after the end of the intervention.
Delayed use of a mobile health application until completion
Participants assigned to the dApp group (delayed use) will not have access to the RomSi app during the first two weeks of the study. During this period, they will complete ecological momentary assessments (EMA) to evaluate stigma, help-seeking intentions, and suicidal ideation, without engaging in the intervention activities associated with the app.
After completing this initial control phase, participants in the dAPP group will begin using the RomSi app, following the same protocol as the iAPP group. This includes interactive activities, such as games designed to foster empathy and understanding, along with continuous access to specialized help contacts.
This crossover design allows for the immediate effects of the intervention to be compared between groups, while also evaluating changes in pre- and post-intervention measures across both conditions.
A follow-up will be carried out one month and three months after the end of the intervention.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have a cell phone with internet access during the intervention and follow-up periods.
* Be able to speak, understand, and read in Spanish.
Exclusion Criteria
* Presence of high social desirability bias (measured during screening, with a score of 14 or higher on the MC-SDS scale).
* Altered mental status that impedes the ability to provide informed consent or assent (e.g., acute psychosis, intoxication, or mania).
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Valencia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rosa M. Baños Rivera
Full Professor of Psycology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Valencia
Valencia, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Rosa María Baños, Professor
Role: backup
Tamara Escrivá-Martínez, PhD
Role: backup
Maitena Pierantonelli, MA
Role: backup
Adriana Mira Pastor, PhD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VH9FA3L6BJ015JSE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.